Breaking News Instant updates and real-time market news.

RYTM

Rhythm Pharmaceuticals

$28.81

-3.8 (-11.65%)

16:50
06/18/18
06/18
16:50
06/18/18
16:50

Rhythm Pharmaceuticals files $150M common stock offering

  • 25

    Jun

RYTM Rhythm Pharmaceuticals
$28.81

-3.8 (-11.65%)

10/30/17
BOFA
10/30/17
INITIATION
Target $30
BOFA
Buy
Rhythm Pharmaceuticals initiated with a Buy at BofA/Merrill
Tazeen Ahman initiated Rhythm Pharmaceuticals with a Buy and $30 price target to reflect the opportunity in rare genetic obesity. Rhythm's lead asset. RM-493, is in late-stage development to treat extreme early onset obesity and he estimates peak sales could reach $1.7B in 2029 across five orphan indications.
10/30/17
10/30/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Sotheby's (BID) initiated with a Buy at Aegis. 2. Alnylam (ALNY) initiated with a Buy at FBR Capital. 3. Adamas Pharmaceuticals (ADMS) initiated with an Outperform at Evercore ISI. 4. Vipshop (VIPS) initiated with a Neutral at UBS. 5. Rhythm Pharmaceuticals (RYTM) initiated with a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/01/17
MSCO
11/01/17
NO CHANGE
Target $23
MSCO
Equal Weight
Rhythm update in BBS patients mixed, says Morgan Stanley
Morgan Stanley analyst Andrew Berens noted that Rhythm Pharmaceuticals announced the presentation of updated data from its Phase 2 trial of setmelanotide in Bardet-Biedl syndrome, or BBS, at the ObesityWeek 2017 meeting. While he anticipated a substantive update on the program by year end, he did not expect this minor update now, noted Berens. One patient lost additional weight and became the first to exceed the 10% weight loss bar, which is an incremental positive, but another discontinued due to a lack of efficacy, an incremental negative, added Berens, who maintains an Equal Weight rating and $23 price target on Rhythm after having initiated coverage of the stock with that rating and target earlier this week.
06/15/18
NEED
06/15/18
NO CHANGE
Target $36
NEED
Buy
Rhythm Pharmaceuticals price target raised to $36 from $32 at Needham
Needham analyst Alan Carr raised his price target on Rhythm Pharmaceutical to $36 after its completed enrollment in the POMC Deficiency and LEPR Deficiency Phase 3 trials. Carr says his conversations with the management have further highlighted the enrollment progress and the expected New Drug Application for both indications in Q3 of 2019. The analyst keeps his Buy rating on Rhythm Pharmaceuticals, also citing its reiterated guidance for updates from the company's Phase 2 program in other patient populations later this month.

TODAY'S FREE FLY STORIES

SELB

Selecta Biosciences

$9.80

-3.57 (-26.70%)

12:47
10/23/18
10/23
12:47
10/23/18
12:47
Recommendations
Selecta Biosciences analyst commentary  »

Selecta Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

SPY

SPDR S&P 500 ETF Trust

$271.39

-3.63 (-1.32%)

, SPX

S&P 500

$0.00

(0.00%)

12:47
10/23/18
10/23
12:47
10/23/18
12:47
Periodicals
Top White House advisor Kudlow says new tax cuts may be delayed, Hill says »

According to the Hill, On…

SPY

SPDR S&P 500 ETF Trust

$271.39

-3.63 (-1.32%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASTE

Astec

$38.42

-8.9 (-18.81%)

12:45
10/23/18
10/23
12:45
10/23/18
12:45
Downgrade
Astec rating change  »

Astec downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

12:45
10/23/18
10/23
12:45
10/23/18
12:45
General news
FX Action: USD-CAD »

FX Action: USD-CAD fell…

KHC

Kraft Heinz

$55.92

-0.3 (-0.53%)

12:41
10/23/18
10/23
12:41
10/23/18
12:41
Periodicals
Kraft Heinz to sell Indian asset portfolio to Zydus, Bloomberg reports »

Kraft Heinz has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 01

    Nov

V

Visa

$137.16

-3.48 (-2.47%)

12:40
10/23/18
10/23
12:40
10/23/18
12:40
Options
Visa calls lead puts 2:1 in heavy option volume as earnings approach »

Visa calls lead puts 2:1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 13

    Nov

  • 26

    Nov

  • 29

    Jan

LH

LabCorp

$166.46

-2.9 (-1.71%)

12:35
10/23/18
10/23
12:35
10/23/18
12:35
Recommendations
LabCorp analyst commentary  »

LabCorp recent selloff…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

ABX

Barrick Gold

$13.36

0.27 (2.06%)

, GOLD

Randgold

$83.26

1.47 (1.80%)

12:35
10/23/18
10/23
12:35
10/23/18
12:35
Hot Stocks
Barrick Gold says Glass Lewis urges holders vote for merger resolutions »

Barrick Gold Corporation…

ABX

Barrick Gold

$13.36

0.27 (2.06%)

GOLD

Randgold

$83.26

1.47 (1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:35
10/23/18
10/23
12:35
10/23/18
12:35
General news
Treasury 2-year auction preview: the auction should go ok »

Treasury 2-year auction…

HZNP

Horizon Pharma

$18.06

-1.19 (-6.18%)

, SELB

Selecta Biosciences

$9.72

-3.65 (-27.30%)

12:33
10/23/18
10/23
12:33
10/23/18
12:33
Recommendations
Horizon Pharma, Selecta Biosciences analyst commentary  »

Cowen says Horizon…

HZNP

Horizon Pharma

$18.06

-1.19 (-6.18%)

SELB

Selecta Biosciences

$9.72

-3.65 (-27.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 07

    Nov

  • 27

    Nov

CIDM

Cinedigm

$0.94

(0.00%)

12:33
10/23/18
10/23
12:33
10/23/18
12:33
Hot Stocks
Cinedigm in partnership with Chinese streaming channel Youku »

Cinedigm announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

OC

Owens Corning

$48.25

-0.47 (-0.96%)

12:32
10/23/18
10/23
12:32
10/23/18
12:32
Downgrade
Owens Corning rating change  »

Owens Corning downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

FXI

iShares China Large-Cap ETF

$39.47

-1.06 (-2.62%)

12:30
10/23/18
10/23
12:30
10/23/18
12:30
Options
50K iShares Large Cap China Fund Dec 42 - 45 call spreads bought for 48c »

50K iShares Large Cap…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$138.10

-0.58 (-0.42%)

, ITCI

Intra-Cellular

$16.83

-0.38 (-2.21%)

12:25
10/23/18
10/23
12:25
10/23/18
12:25
Conference/Events
JPMorgan pharma and biotech analysts to hold analyst/industry conference call »

Smid Cap Biotech Analyst…

JNJ

Johnson & Johnson

$138.10

-0.58 (-0.42%)

ITCI

Intra-Cellular

$16.83

-0.38 (-2.21%)

AGN

Allergan

$185.90

-1.85 (-0.99%)

SAGE

Sage Therapeutics

$118.28

0.25 (0.21%)

ALKS

Alkermes

$39.00

0.14 (0.36%)

ACAD

Acadia

$21.76

-0.01 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 28

    Oct

  • 30

    Oct

  • 01

    Nov

  • 02

    Nov

  • 06

    Nov

  • 06

    Nov

  • 06

    Nov

  • 19

    Dec

  • 31

    Jan

EDU

New Oriental Education

$52.99

-9.76 (-15.55%)

12:22
10/23/18
10/23
12:22
10/23/18
12:22
Downgrade
New Oriental Education rating change  »

Follow-up: New Oriental…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 01

    Nov

  • 02

    Nov

TSLA

Tesla

$279.50

18.47 (7.08%)

12:21
10/23/18
10/23
12:21
10/23/18
12:21
Periodicals
Mox Reports joins Citron in going long Tesla »

Mox Reports tweeted:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

IQV

Iqvia

$119.62

-6.74 (-5.33%)

12:20
10/23/18
10/23
12:20
10/23/18
12:20
Options
Vote of confidence in IQVIA Holdings after earnings »

Vote of confidence in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NXE

NexGen Energy

$1.89

-0.085 (-4.30%)

12:17
10/23/18
10/23
12:17
10/23/18
12:17
Conference/Events
NexGen Energy management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
10/23/18
10/23
12:17
10/23/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
10/23/18
10/23
12:16
10/23/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEM

Agnico Eagle

$37.18

0.91 (2.51%)

12:15
10/23/18
10/23
12:15
10/23/18
12:15
Options
Agnico Eagle put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

EDU

New Oriental Education

$52.96

-9.79 (-15.60%)

12:13
10/23/18
10/23
12:13
10/23/18
12:13
Downgrade
New Oriental Education rating change  »

New Oriental Education…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 01

    Nov

  • 02

    Nov

AAPL

Apple

$217.24

-3.38 (-1.53%)

, SPOT

Spotify

$146.50

-2.01 (-1.35%)

12:12
10/23/18
10/23
12:12
10/23/18
12:12
Periodicals
Pandora executive admits to late timing of premium offering, VB says »

According to Venture…

AAPL

Apple

$217.24

-3.38 (-1.53%)

SPOT

Spotify

$146.50

-2.01 (-1.35%)

P

Pandora

$8.47

-0.12 (-1.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

ANFGY

Antofagasta

$0.00

(0.00%)

12:08
10/23/18
10/23
12:08
10/23/18
12:08
Conference/Events
Antofagasta management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

MCD

McDonald's

$175.30

8.77 (5.27%)

, CAT

Caterpillar

$118.17

-10.47 (-8.14%)

12:07
10/23/18
10/23
12:07
10/23/18
12:07
OnTheFly
Fly Intel: Wall Street's top stories at midday »

Stocks opened sharply…

MCD

McDonald's

$175.30

8.77 (5.27%)

CAT

Caterpillar

$118.17

-10.47 (-8.14%)

MMM

3M

$187.86

-13.55 (-6.73%)

UTX

United Technologies

$127.36

0.94 (0.74%)

VZ

Verizon

$57.08

2.12 (3.86%)

TSLA

Tesla

$276.95

15.92 (6.10%)

CDNS

Cadence Design

$45.20

4.58 (11.28%)

PHM

PulteGroup

$22.27

1.39 (6.66%)

AMAT

Applied Materials

$33.16

-0.36 (-1.07%)

MC

Moelis

$42.49

-8.17 (-16.13%)

CNC

Centene

$130.47

-10.865 (-7.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

  • 01

    Nov

  • 12

    Nov

  • 13

    Nov

  • 13

    Dec

  • 14

    Dec

  • 12

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.